Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Revenue
Annual & quarterly revenue history · segment & region breakdown
BNGO · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsBionano Genomics, Inc. trailing twelve-month (TTM) revenue is $0.03B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bionano Genomics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bionano Genomics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bionano Genomics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BNGO revenue · 4 questionsBNGO's trailing twelve-month (TTM) revenue is $0.03B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Bionano Genomics, Inc. SEC filings · GAAP · Bionano Genomics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026